Dow Pharmaceutical Sciences Inc

Rating: 0 - Write A Review
1330 Redwood WAy
Petaluma, CA 94954
About Dow Pharmaceutical Sciences Inc
  • In the past 3 years alone, Dow Pharmaceutical Sciences, Inc., a privately held company in Northern California, has sucessfully developed topical products for 65 clients. Using our unique optimization process which includes in-house in vitro pentration studies, we develop stable formulations that include only disease compatible excipients, that pentrate the skin as desired, and that can be scaled up . For 30 years we have focused only on topicals (derm, eye, etc) so we know what problems occur and how to solve them. We have developed more Rx topical products than any other company in the world. Everything you need is in one location at Dow, and if you work with Dow you have access to all of our experience and expertise. Topicals are our focus, and you best chance of success is at Dow. In 2005-06, 14 topical Rx products were approved by the FDA; formulations for 8 of these products were developed at Dow.
Competitors of Dow Pharmaceutical Sciences Inc
  • Swiss-American CDMO

    Swiss-American Contract Development and Manufacturing specializes in topical skin and wound care products. Our product development and manufacturing processes are complemented by a flexible and innovative R&D capability. For more than 25 years, leading healthcare brands have relied on our... Read More
  • Importfab Inc.

    IMPORTFAB is a well-established contract manufacturer, specialized in the manufacturing and packaging of non-sterile semi-solids (ointments, creams, gels, lotions), liquids and suspensions for the pharmaceutical and cosmetic industries. Since 1990, IMPORTFAB has been considered a reliable...
  • Catalent Pharma Solutions Inc

    Catalent offers a full range of development services, such as pre-clinical support, API development, analytical services, drug delivery development, clinical manufacturing and packaging services. We have expertise in inhalation development, and can offer innovative biologic cell-line development...